Allevi;BioBots

Developer of 3D bioprinters and bioinks intended to cure disease, eliminate the organ waiting list and reverse climate change. The company's 3D bioprinters and bioinks provide a printer that uses a special ink combined with biomaterials and living cells to bui

Operating in biotech & life sciences based in United States, Allevi;BioBots operates.

Profile

Developer of 3D bioprinters and bioinks intended to cure disease, eliminate the organ waiting list and reverse climate change. The company's 3D bioprinters and bioinks provide a printer that uses a special ink combined with biomaterials and living cells to build 3D living tissue and miniature human organs to unleash the biological revolution

Within the biotech & life sciences space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in United States.

It is recorded at the Exited stage.

Website: www.allevi3d.com